In plaque psoriasis, interleukin-23 (IL-23) is a protein that plays a key role in inflammation.
When IL-23 binds with its receptor, inflammation can occur in the body.
ICOTYDE targets the IL-23 receptor, which blocks IL-23 from binding.
This prevents the release of inflammatory proteins.*
*The clinical significance of these findings is unknown.
IL-23R, interleukin-23 receptor.
